ICU Medical ICUI Business Segments
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| Revenue, Remaining Performance Obligation, Amount by Product | ||||||
| Equipment revenue | $50.94M+153% | $24.53M+43.9% | $20.34M+38.9% | $12.3M-42.1% | $20.11M+0.5% | |
| Government Grant Revenue | $4.77M-30.2% | $5.28M-28.1% | $5.8M-26.3% | $6.32M-24.6% | $6.83M-23.2% | |
| Other deferred revenue | $1.38M-17.4% | $888K+2,860% | $611K+1,355% | $890K+24.1% | $1.66M+120% | |
| Software revenue | $6.28M-27.4% | $6.36M-43.3% | $5.88M-42.2% | $6.67M-31.8% | $8.65M-12.9% | |
| Revenue by Product | ||||||
| Infusion Consumables | $278.28M+4.5% | $284.68M+6.2% | $285.09M+7.6% | $273.13M+4.3% | $266.23M+9.1% | |
| Infusion Systems | $179.6M+8.0% | $176.3M+2.7% | $173.91M+8.9% | $167.7M+2.5% | $166.3M+5.7% | |
| Vital Care | $72.35M-58.0% | $79.72M-58.0% | $77.99M-52.6% | $108.04M-36.8% | $172.18M+4.2% | |
| Revenue by Geography | ||||||
| Asia Pacific | $58.3M-1.9% | —— | $57.48M-4.7% | $58.4M-4.6% | $59.41M+14.6% | |
| UNITED STATES | $315.5M-18.7% | $325.31M-21.3% | $307.13M-16.9% | $335.43M-12.5% | $388.25M+6.0% | |
| Total property and equipment, cost by Geography | ||||||
| Asia Pacific | $27.26M-0.4% | $28.24M+2.5% | $28.8M— | $29.75M— | $27.37M— | |
| CANADA | $2.12M+41.9% | $1.98M-62.5% | $1.9M— | $1.92M— | $1.49M— | |
| COSTA RICA | $169.75M+7.7% | $168.68M+8.0% | $163.69M— | $160.68M— | $157.58M— | |
| CZECHIA | $9.54M-24.2% | $14.11M+18.5% | $13.93M— | $13.8M— | $12.58M— | |
| Europe | $11.58M+7.5% | $11.49M+0.3% | $11.56M— | $11.58M— | $10.77M— | |
| Foreign | $479.42M+11.2% | $479.94M+12.9% | $464.76M— | $454.1M— | $431.03M— | |
| ITALY | $35M+12.6% | $35.47M+21.8% | $34.98M— | $34.56M— | $31.09M— | |
| MEXICO | $128.97M+14.8% | $127.39M+14.7% | $122.52M— | $117.84M— | $112.38M— | |
| Other LATAM | $73.16M+22.6% | $71.05M+28.1% | $67.33M— | $64.06M— | $59.66M— | |
| SPAIN | $22.04M+21.7% | $21.53M+25.6% | $20.05M— | $19.91M— | $18.12M— | |
| UNITED STATES | $626.44M+1.2% | $617.79M+1.2% | $626.83M— | $628.67M— | $618.86M— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How does ICU Medical break its business down?
- ICU Medical (ICUI) reports revenue, remaining performance obligation, amount by product across 4 parts — Equipment revenue, Government Grant Revenue, Other deferred revenue and Software revenue. Each is extracted from the segment footnotes and tracked over time.
- Where does ICU Medical's segment data come from?
- Segment breakdowns are pulled from the segment footnotes in ICU Medical's SEC filings (the XBRL dimensional tags), so every line ties back to a reported figure. Switch between quarterly, annual, and TTM, or open any segment for its full history.